← Open Payments lookup

REBECCA MAXWELL: Open Payments

NPI 1235757238 · LAKEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,920 in 91 payments from 25 companies in 2025. Trend: 2023 $1,204 · 2024 $1,124 · 2025 $2,920

Food & beverage: $2,020Consulting: $900
CompanyPaymentsAmount
GlaxoSmithKline, LLC.9$1,120
GENZYME CORPORATION20$343
AstraZeneca Pharmaceuticals LP14$308
Regeneron Healthcare Solutions, Inc.11$177
Boehringer Ingelheim Pharmaceuticals, Inc.4$123
Inspire Medical Systems, Inc.1$114
Takeda Pharmaceuticals U.S.A., Inc.3$85
Philips North America LLC3$76
Merck Sharp & Dohme LLC3$69
Bayer Healthcare Pharmaceuticals Inc.3$67

Products named: NUCALA, DUPIXENT, INSPIRE, FASENRA, BREZTRI, Vest Therapy Und, WINREVAIR, Adempas.

Industry payments across CO — which companies pay providers there.